BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:5th Annual Chemical Biology &amp\; Molecular Medicine Symposium - 
 Department of Chemistry\, University of Cambridge
DTSTART:20111010T074500Z
DTEND:20111010T170000Z
UID:TALK33029@talks.cam.ac.uk
CONTACT:Dr Rebecca Myers
DESCRIPTION:CANCER THEME\n\nThe Cambridge PhD Training Programme in Chemic
 al Biology & Molecular Medicine will be holding its annual symposium on th
 e Addenbrooke’s site at the Cancer Research UK Cambridge Research Instit
 ute on Monday 10th October. \n\nSpeakers will include:\n\n%{color:red}TOM 
 HEIGHTMAN% (Director of Medicinal Chemistry\, Astex) our annual keynote le
 cture – *Epigenetic Drug Discovery*\n\n%{color:red}KJ PATEL% (MRC Labora
 tory of Molecular Biology) – *Protecting Against the Genotoxic Consequen
 ces of Naturally Produced Reactive Aldehydes*\n\n%{color:red}STEVE JACKSON
 % (Wellcome Trust/CRUK Gurdon Institute) – *Cellular Responses to DNA Da
 mage: Drug Discovery and Drug Evaluation*\n\n\nPlus research updates from 
 the programme’s PhD students:\n\n*Developing a Novel Approach Towards 
 “Synthetic Lectins” with the View of Imaging Cancer Cell Glycoproteins
 * (Yelena Wainman)\n \n*Genetic Instability and Cancer: Inhibiting Aurora 
 Kinase A and TPX2 Interaction* (Matej Janecek)\n \n*Designing Novel Bioort
 hogonal Reactions for the Site-Selective Glycosylation of Proteins* (Lily 
 Chan)\n \n*DNA Modifications and Epigenetic Processes in Cancer Progressio
 n and Metastasis* (Martin Bachman)\n \n*Fragment Based Design of Inhibitor
 s of the TPX2-Importin-α Interaction* (Rhian Holvey)\n \n*Biophysical Eva
 luation of the Rad51-BRCA2 Protein-Protein Interaction and the Design and 
 Synthesis of Inhibitors* (Luca Laraia)\n \n*Synthesis and Biological Evalu
 ation of Allosteric Inhibitors of the Motor Protein\, HSET* (Ciorsdaidh Wa
 tts)\n \n*New Approaches in Epigenetic Therapy: Non-coding RNA as a Target
  for Polycomb Inhibition* (Liang Wu)\n \n*Unravelling Uncinatone: Piecing 
 Together the Clues Towards a Potential Topoisomerase II Inhibitor* (Andrew
  Lewis)\n \n*Allosteric Polo-like Kinase 1 Inhibitors: A Fragment-Based Ap
 proach* (Christopher Stubbs)\n \n*Development of Novel Small Molecule Inhi
 bitors of XIAP-Caspase 9 Interactions* (Danny Allwood)\n \n*Cyclopamine: I
 nspiration for Novel Inhibitors of the Hedgehog Signalling Pathway* (Ellio
 tt Bayle)\n \n*Ruthenium-based Enzyme Inhibitors: Pioneering a New Generat
 ion of Metallodrugs* (Simon Page)\n\n \nThere will also be a POSTER SESSIO
 N. There is still space to accommodate a few more posters. If you are inte
 rested in presenting your relevant research please contact me asap. The sy
 mposium is *free to attend* – but please email rmm32@cam.ac.uk to regist
 er ASAP. \n\nSee programme website for further details: http://www-medchem
 .ch.cam.ac.uk/
LOCATION:CRUK Cambridge Research Institute\, Li Ka Shing Centre\, Robinson
  Way\, Cambridge\, CB2 0RE
END:VEVENT
END:VCALENDAR
